Molecular and cellular responses to oxidative stress and changes in oxidation-reduction imbalance in the intestine

American Journal of Clinical Nutrition

Volumn 70, Issue 4, 1999, Pages 557-565

  Aw, Tak Yee ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Carcinogenesis; Cell cycle responses; Dietary lipid peroxides; Intestine; NF B; Nuclear transcription factor B; Oxidation reduction imbalance; Oxidative stress; Peroxidized lipids; Proliferation

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANIMAL CELL; APOPTOSIS; CARCINOGENESIS; CELL FUNCTION; CELL PROLIFERATION; CONFERENCE PAPER; FAT INTAKE; INFLAMMATORY CELL; INTESTINE MUCOSA; LIPID PEROXIDATION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; TRANSCRIPTION REGULATION;

EID: 0000092645     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/70.4.557     Document Type: Conference Paper

References (67)

1. Miller DL, Hanson W, Schedl HP, Osborne JW. Proliferation rate and transit time of mucosal cells in small intestine of the diabetic rat. Gastroenterology 1977;73:1326-32.
2. Ames B. Dietary carcinogens and anticarcinogens. Science 1983;221:1256-63.
3. Sevanian A, Hochstein P. Mechanisms and consequences of lipid peroxidation in biological systems. Annu Rev Nutr 1985;5:365-90.
4. Girotti AW. Mechanisms of lipid peroxidation. J Free Radic Biol Med 1985;1:87-95.
5. Grisham MB, Granger DN. Neutrophil-mediated mucosal injury. Role of reactive oxygen metabolites. Dig Dis Sci 1988;33:6S-15S.
6. Parks DA, Bulkley GB, Granger DN. Role of oxygen-derived free radical in digestive tract diseases. Surgery 1983;94:415-22.
7. Andrews JS, Griffith WH, Mead JF, Stein RA. Toxicity of air-oxidized soybean oil. J Nutr 1960;70:199-210.
8. Kaneda T, Sakai H, Ishii S. Nutritive value or toxicity of highly unsaturated fatty acids. J Biochem 1955;42:561-73.
9. Aw TY, Tsunada S. Persistent subtoxic lipid peroxide challenge in vivo causes thiol redox imbalance and cytostasis in rat intestine. FASEB J 1997;11:A219 (abstr).
10. Tsunada S, Aw TY. Epidermal growth factor reverses lipid peroxide-induced cytosis in rat intestine. FASEB J 1997;11:A220 (abstr).
11. Correa P, Strong JP, Johnson WD, Pizzolato P, Haenszel W. Atherosclerosis and polyps of the colon. Quantification of precursors of coronary heart disease and colon cancer. J Chronic Dis 1982;35:313-20.
12. Carroll KK, Khor HT. Dietary fat in relation to tumorigenesis. Prog Biochem Pharmacol 1975;10:308-53.
13. Reddy BS. Dietary fat and colon cancer. In: Antrup H, Williams GM, eds. Experimental colon carcinogenesis. Boca Raton, FL: CRC Press, 1983:225-39.
14. Bull AW, Nigro ND, Golembieski WA, Crissman JD, Marnett LJ. In vivo stimulation of DNA synthesis and induction of ornithine decarboxylase in rat colon by fatty acid hydroperoxides, autoxidation products of unsaturated fatty acids. Cancer Res 1984;44:4924-8.
15. Verma AK, Ashenden CL, Boutwell RK. Inhibition of prostaglandin synthesis inhibitors of the induction of epidermal ornithine decarboxylase activity, the accumulation of prostaglandin, and tumor promotion caused by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res 1980;40:308-15.
16. Fischer SM, Gleason GL, Mills GD, Slaga JJ. Indomethacin enhancement of TPA tumor promotion in mice. Cancer Lett 1980;10:343-50.
17. Yagi K, Ohkawa H, Ohishi N, Yamashita M, Nakashima T. Lesions of aortic intima caused by intravenous injection of linoleic acid hydroperoxide. J Appl Biochem 1981;3:58-65.
18. Steinberg D, Parthasarathy TE, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-24.
19. Kaplowitz N, Aw TY, Ookhtens M. The regulation of hepatic glutathione. Annu Rev Pharmacol Toxicol 1985;25:715-44.
20. Shan X, Aw TY, Jones DP. Glutathione-dependent protection against oxidative injury. Pharmacol Ther 1990;47:61-71.
21. Aw TY, Williams MW, Gray L. Absorption and lymphatic transport of peroxidized lipids by rat small intestine in vivo: role of mucosal glutathione. Am J Physiol 1992;262:G99-106.
22. Aw TY, Williams MW. Effect of glutathione supplementation on absorption and lymphatic transport of peroxidized lipids by rat small intestine in vivo. Am J Physiol 1992;263:G665-72.
23. Aw TY. Biliary glutathione promotes the mucosal metabolism of luminal peroxidized lipids by rat small intestine in vivo. J Clin Invest 1994;94:1218-25.
24. Hagen TM, Brown LA, Jones DP. Protection against paraquat induced injury by exogenous GSH in pulmonary alveolar type II cells. Biochem Pharmacol 1986;35:4537-42.
25. Hagen TM, Aw TY, Jones DP. Glutathione uptake and protection against oxidative injury in isolated kidney cells. Kidney Int 1988;34:74-81.
26. Andreoli SP, Mallett CP, Bergstein JM. Role of glutathione in protecting endothelial cells against hydrogen peroxide oxidant injury. J Lab Clin Med 1986;108:190-8.
27. Lash LH, Hagen TM, Jones DP. Exogenous glutathione protects intestinal epithelial cells from oxidative injury. Proc Natl Acad Sci USA 1986;83:4641-5.
28. Wierzbicka GT, Hagen TM, Jones DP. Glutathione in food. J Food Comp Anal 1989;2:327-37.
29. Jones DP, Coates RJ, Flagg EW, et al. Glutathione in foods listed in the National Cancer Institute's Health Habits and History food frequency questionnaire. Nutr Cancer 1992;17:57-75.
30. Frankel EN, Smith LM, Hamblin CL, Creveling AJ, Clifford RK. Occurrence of cyclic fatty acid monomers in frying oils used for fast foods. J Am Oil Chem Soc 1984;61:87-90.
31. Alexander JC. Heated and oxidized fats. Prog Clin Bio Res 1986;222:185-209.
32. Yagi K, Kiuchi K, Saito Y, et al. Use of a new methylene blue derivative for determination of lipid peroxides in foods. Biochem Int 1986;12:367-71.
33. Brigelius R. Mixed disulfides: biological functions and increase in oxidative stress. In: Sies H, ed. Oxidative stress. New York: Academic Press, 1985:243-72.
34. Beach D, Basilico C, Newport J, eds. Current communication in molecular biology. Cell cycle control in eukaryotes. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1988.
35. Flores SC, McCord JM. Redox regulation by the HIV-1 Tat transcriptional factor. In: Scandalios JG, ed. Oxidative stress and the molecular biology of antioxidant defenses. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1997:117-38.
36. Cepinskas G, Kvietys PR, Aw TY. The cytotoxicity of peroxidized omega-3 lipids on cultured human epithelial cells is related to the development of cellular GSH-dependent antioxidant systems. Gastroenterology 1994;107:80-6.
37. Walker PR, Smith C, Youdale T, Leblanc J, Whitfield JF, Sikorska M. Topoisomerase II-reactive chemotherapeutic drugs induce apoptosis in thymocytes. Cancer Res 1991;51:1078-85.
38. Kaufmann SH. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res 1989;49:5870-8.
39. Liu LF. DNA topoisomerase poisonous as antitumor drugs. Annu Rev Biochem 1989;58:351-75.
40. Manning AM, Anderson DC. Transcriptional factor NFκB: an emerging regulator of inflammation. In: Lee JC, ed. Annual reports in medicinal chemistry. New York: Academic Press, 1994:235-44.
41. Schulze-Osthoff K, Beyaert R, Vandevoorde V, Haegerman G, Fiers W. Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. EMBO J 1993;12:3095-104.
42. Schultze-Osthoff K, Bakker AC, Vanhaesbrieck B, Bayeart R, Jacob WA, Fiers W. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. J Biol Chem 1992;267:5317-23.
43. Hennet T, Richter C, Peterhans E. Tumor necrosis factor-κ induces superoxide anion generation in mitochondria of L929 cells. Biochem J 1993;289:587-92.
44. Schreck R, Meier B, Mannel DN, Droge W, Baeuerle PA. Dithiocarbamates as potent inhibitors of nuclear factor κB activation in intact cells. J Exp Med 1992;175:1181-94.
45. Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor HIV-1. EMBO J 1991;10:2247-58.
46. Ichikawa H, Flores SC, Kvietys PR, et al. Molecular mechanisms of anoxia/reoxygenation-induced neutrophil adherence to cultured endothelial cells. Circ Res 1997;81:922-31.
47. Staal FJ, Roederer M, Herzenberg LA. Intracellular thiols regulate activation of nuclear factor KB and transcription of human immunodeficiency virus. Proc Natl Acad Sci U S A 1990;87:9943-7.
48. Mihm S, Ennen J, Pessara U, Kurth R, Droge W. Inhibition of HIV-1 replication and NF-κB activity by cysteine and cysteine derivatives. AIDS 1991;5:497-503.
49. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NFκB and cytokine-inducible enhancers. FASEB J 1995;9:889-909.
50. Schmidt KN, Amstad P, Cerutti P, Baeuerle PA. The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NFKB. Chem Biol 1995;2:13-22.
51. 2+ concentration. Arch Biochem Biophys 1989;269:365-70.
52. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980;284:555-6.
53. Wyllie AH, Morris RG. Hormone-induced cell death: purification and properties of thymocytes undergoing apoptosis after glucocorticoid treatment. Am J Pathol 1982;109:78-87.
54. 2+-mediated endonuclease activation in chemical toxicity. In: Dekant W, Neumann HG, eds. Tissue-specific toxicity: biochemical mechanisms. London: Academic Press, 1992:1-14.
55. Aw TY, Nicotera P, Manzo L, Orrenius S. Tributyltin stimulates apoptosis in rat thymocytes. Arch Biochem Biophys 1990;283:46-50.
56. McConkey DJ, Orrenius S. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) kills glucocorticoid-sensitive thymocytes in vivo. Biochem Biophys Res Commun 1989;160:1003-8.
57. 2+-mediated endonuclease activation. Science 1988;242:256-9.
58. Lee FD. Importance of apoptosis in the histopathology of drug related lesions in the large intestine. J Clin Pathol 1993;46:118-22.
59. Ijiri K. Apoptosis (cell death) induced in mouse bowel by 1,2-dimethylhydrazine methlazoxymethanol acetate, and κ-rays. Cancer Res 1989;49:6342-6.
60. Potten CS. The significance of spontaneous and induced apoptosis in the gastrointestinal tract of mice. Cancer Metastasis Rev 1992;11:179-95.
61. MacLellan WR, Schneider MD. Death by design. Programmed cell death in cardiovascular biology and disease. Circ Res 1997;81:137-44.
62. Read MA, Whitley MZ, Williams AJ, Collins T. NFκB and IκB: an inducible regulatory system in endothelial activation. J Exp Med 1994;179:503-12.
63. Read MA, Neish AS, Luscinskas FW, Palombella VJ, Maniatis T, Collins T. The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression. Immunity 1995;2:493-506.
64. Adams J, Stein R. Novel inhibitors of the proteasome and their therapeutic use in inflammation. In: Wong, ed. Annual reports in medicinal chemistry. New York: Academic Press, 1996:279-88.
65. Cobb RR, Felts KA, Parry GCN, Mackman N. Proteasome inhibitors block VCAM-1 and ICAM-1 gene expression in endothelial cells without affecting nuclear translocation of nuclear factor KB. Eur J Immunol 1996;26:839-45.
66. Bielinska A, Shivdasani RA, Zhang L, Nabel GJ. Regulation of gene expression with double-stranded phosphorothioate oligonucleotides. Science 1990;250:997-1000.
67. Aw TY, ed. Oxidants and thiol redox control in the gastrointestinal tract. Comp Biochem Physiol 1997;118B:471-97.